DAVID GRANOVSKY

Posts Tagged ‘reuter’

REUTERS UPDATE

In ALL ARTICLES on January 4, 2012 at 12:09 pm
UK wants results of breast implant review this week
LONDON (Reuters) – Britain expects the results of a review of breast implant safety to come this week following a global health scare focused on products from a now defunct French company, Health Secretary Andrew Lansley said on Wednesday. | Full Article
Want your kids to do better in school? Try exercise
January 04, 2012 08:17 AM ET
(Reuters) – Children who get more exercise also tend to do better in school, whether the exercise comes as recess, physical education classes or getting exercise on the way to school, according to an international study. | Full Article
Daycare providers say kids are too inactive
January 04, 2012 09:22 AM ET
NEW YORK (Reuters Health) – Potential playground hazards, a focus on classroom learning and boring play equipment have children spending too little time being physically active at daycare, according to a survey of staff members at child care centers in Ohio. | Full Article

Reuters Health Update

In ALL ARTICLES on April 25, 2011 at 11:13 am
Pediatricians call for stricter laws for chemicals
NEW YORK (Reuters Health) – The U.S. is not doing enough to protect kids from exposure to potentially dangerous chemicals, pediatricians said in a new statement released today. | Full Article
China considers financial incentives to promote organ donation
April 25, 2011 04:59 AM ET
BEIJING (Reuters) – The Chinese government is considering offering financial incentives to people to voluntarily donate organs, state media said on Monday, as the country tries to tackle the problem of demand for transplants outstripping supply. | Full Article
Bullying sends kids to nurse for more than injury
April 25, 2011 01:28 AM ET
NEW YORK (Reuters Health) – Both bullies and their victims take more trips to the nurse’s office than other students – but not just for the obvious reasons. | Full Article
US FDA sees safety issue with Merck hepatitis drug
April 25, 2011 08:57 AM ET
WASHINGTON (Reuters) – U.S. drug reviewers have raised questions about safety issues with an experimental Merck & Co hepatitis drug, including anemia and reports of psychiatric problems, documents released on Monday said. | Full Article
Diabetic completes first-ever polar flight of its kind
April 23, 2011 08:09 PM ET
ANCHORAGE, Alaska (Reuters) – Former British Royal Air Force pilot Douglas Cairns succeeded in flying his light plane to the North Pole and landing it there this week, overcoming strong headwinds, the failure of his satellite-based navigation system and his diabetes to earn a place in aviation record books. | Full Article

PRESCRIPTION DRUG EPIDEMIC

In ALL ARTICLES on April 20, 2011 at 11:32 am

anyone else enjoying the irony of these articles getting released on 420?? -dg

White House announces plans to reduce prescription drug abuse

WASHINGTON (Reuters) – President Barack Obama’s administration unveiled on Tuesday a plan to fight what it calls a prescription drug abuse epidemic. | Full Article

FDA unveils new action on prescription drug abuse

April 19, 2011 02:35 PM ET

WASHINGTON (Reuters) – The U.S. health regulator ordered painkiller makers to provide educational materials to help train physicians about the correct use of the drugs, as part of the Obama administration’s plan to tackle prescription drug abuse. | Full Article

https://i0.wp.com/www.clevespolice.us/images/drugabuse.jpg

Roche’s diet drug tied to kidney damage | Reuters

In OFF THE BEATEN PATH on April 13, 2011 at 10:39 am

More bad news about drugs. – dg

https://repairstemcell.files.wordpress.com/2011/04/prescriptiondietpills.jpg?w=174

“In another blow to diet drugs, Canadian researchers are reporting a link between Roche’s Xenical and an increase in kidney injuries. Tapping into healthcare databases from the province of Ontario, they found that 0.5 percent of new orlistat users were hospitalized for kidney problems in the year before starting on the drug. Over the next year, that number jumped to 2 percent.”

Roche did not return calls for comments in time for this article.”

Dr. Donald E. Greydanus, a pediatrician at Michigan State University, who was not involved in the study but has written on obesity treatments [said:] “There is no safe panacea drug that works and that has no side effects,” he told Reuters Health in an email.

While 2% seems low to you and me, consider that this is kidney damage from a diet drug AND a 400% increase over typical incidents.

https://i0.wp.com/www.mccullagh.org/db9/1ds2-4/kidney-beans.jpg

Roche’s diet drug tied to kidney damage | Reuters.

 

Heart drug linked to higher breast cancer risk | Reuters

In PHARMA AND DRUGS on March 23, 2011 at 1:44 pm

Heart drug linked to higher breast cancer risk

Women taking the heart drug digoxin have an increased risk of breast cancer, according to a study of more than 2 million Danes.

By Genevra Pittman – NEW YORK | Tue Mar 22, 2011 5:27pm EDT

(Reuters Health) –

Digoxin, marketed as Lanoxin and Digitek, is used by people with heart failure or with abnormal heart beats. But it can also act like the female hormone estrogen in the body…

those currently on it were about 40 percent more likely to get breast cancer.

https://i1.wp.com/breast-cancer-treatments.net/wp-content/uploads/2010/01/breast-cancer.jpg

Heart drug linked to higher breast cancer risk | Reuters.

U.S. court rules against Obama’s stem cell policy | Reuters

In STEM CELLS IN THE NEWS on August 23, 2010 at 9:50 pm

A U.S. court ruled in favor of a law suit filed in June against the National Institutes of Health by researchers.   The preliminary injunction on Monday stops federal funding of human embryonic stem cell research under the position that “human embryonic stem cell research involved the destruction of human embryos.”  Christian groups also opposed to embryo research argued the NIH policy violated U.S. law and took funds from researchers seeking to work with adult stem cells.

While this ruling is based on moral issues and not scientific issues, there is a preponderance of evidence that scientifically, embryonic stem cells for treatment may prove to be a dead end for at least 20-50 years and adult stem cells are already proven safe and effective for treating over 130+ diseases in humans.  For more information on why adult stem cells are scientifically better suited for treating humans than embryonic stem cells, read these articles:

U.S. court rules against Obama’s stem cell policy

A microscopic view shows smooth muscle cells derived from human  embryonic stem cells showing the nuclei (blue) and proteins of the  cytoskeleton (green) in this handout photo released to Reuters by the  California Institute for Regenerative Medicine, March 9, 2009.  REUTERS/Alexey Terskikh/Burnham Institute for Medical  Research/California Institute for Regenerative Medicine/Handout

WASHINGTON | Mon Aug 23, 2010 6:22pm EDT

WASHINGTON (Reuters) – A U.S. district court issued a preliminary injunction on Monday stopping federal funding of human embryonic stem cell research, in a slap to the Obama administration’s new guidelines on the sensitive issue.

The court ruled in favor of a suit filed in June by researchers who said human embryonic stem cell research involved the destruction of human embryos.

Judge Royce Lamberth granted the injunction after finding the lawsuit would likely succeed because the guidelines violated law banning the use of federal funds to destroy human embryos.

“(Embryonic stem cell) research is clearly research in which an embryo is destroyed,” Lamberth wrote in a 15-page ruling. The Obama administration could appeal his decision or try to rewrite the guidelines to comply with U.S. law.

The suit against the National Institutes of Health, backed by some Christian groups opposed to embryo research, argued the NIH policy violated U.S. law and took funds from researchers seeking to work with adult stem cells.

The U.S. Department of Justice, White House and NIH had no immediate comment.

Key to the case is the so-called Dickey-Wicker Amendment, which Congress adds to budget legislation every year. It bans the use of federal funds to destroy human embryos.

That was not an issue for the NIH until the discovery of human embryonic stem cells in 1998. In 2001, then-President George W. Bush said he could only allow federal research money to pay for work done using a few batches, or lines, of the cells.

Many stem cell researchers objected, saying they could not do work needed to fulfill the promise of the powerful cells, which can give rise to all the tissues and cells in the human body. Privately funded researchers could do as they pleased, but federal funding is the cornerstone of such basic biological research.

NEW POLICY

As one of his first acts after taking office, Obama overturned that decision and the NIH set up a careful process for deciding which batches of human embryonic stem cells could be used by federally funded researchers.

The new guidelines do not allow the use of federal dollars to create the stem cells but do allow researchers to work with them if they are made by another lab.

Dr. James Sherley of Boston Biomedical Research Institute and Theresa Deisher of Washington-based AVM Biotechnology, who both work with adult stem cells, filed the original suit saying the guidelines would harm their work by increasing competition for limited federal funding. They both oppose the use of human embryonic stem cells.

Sherley was not immediately available for comment.

“There is no after-the-fact remedy for this injury because the Court cannot compensate plaintiffs for their lost opportunity to receive funds,” Lamberth wrote.

He found that the injunction would not seriously harm researchers who focus on human embryonic stem cells because it would preserve the status quo and not interfere with their ability to get private funding.

With the preliminary injunction in place, the two sides will likely present arguments and case history to the judge over whether the guidelines can be permanently blocked or be allowed to go into effect.

(Editing by Peter Cooney)

via U.S. court rules against Obama’s stem cell policy | Reuters.

%d bloggers like this: